Cardiometabolic & kidney

Electronic Nudge Letters to Increase Influenza Vaccination Uptake in Younger and Middle-Aged Individuals With Diabetes

JACC AdvPublished Secondary analysis of the NUDGE-FLU-CHRONIC randomised trial

Authors' conclusion

Electronic nudge letters effectively boosted vaccine uptake in individuals with DM and in individuals free of DM but with other chronic diseases, but the effect was lower among those with DM.

Study context

Population
Danish citizens aged 18–64 years with chronic disease, with vs without diabetes mellitus (DM), 2023/2024 influenza season57,666 (19.2%) with DM
Participants
299,881 participants
Comparison
Any electronic nudge letter vs usual care, by DM status
Primary endpoint
Receipt of a seasonal influenza vaccine
Follow-up
On or before January 1, 2024
Methodological detailsnationwide, pragmatic implementation trial, randomized 2.45:1:1:1:1:1:1
  • Nationwide
  • Pragmatic implementation trial
  • Randomized 2.45:1:1:1:1:1:1

Primary result

As reported in the abstract

Influenza vaccine uptake, by DM status (subgroups)
Electronic letter vs Usual careEstimate (99.29% CI)
DM
relative risk ratio 1.42(1.39–1.44)
Without DM
risk ratio 1.47(1.45–1.50)
DM: 45.6% vs 36.5%
difference +9.1 percentage points (99.29% CI 7.9–10.3)
Without DM: 37.3% vs 25.9%
difference +12.3 percentage points (99.29% CI 11.7–12.8)

Further findings

Vaccine uptake during the season, DM vs without DM

DM vs without DM: 43.0% vs 34.6%
P < 0.001

Original publication

Electronic Nudge Letters to Increase Influenza Vaccination Uptake in Younger and Middle-Aged Individuals With Diabetes. JACC Adv. Published 13 November 2024. doi:10.1016/j.jacadv.2024.101391

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.